Nissui Pharmaceutical Co Ltd
TSE:4550

Watchlist Manager
Nissui Pharmaceutical Co Ltd Logo
Nissui Pharmaceutical Co Ltd
TSE:4550
Watchlist
Price: 999 999.9999 JPY Market Closed
Market Cap: ¥38.3B

Nissui Pharmaceutical Co Ltd
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Nissui Pharmaceutical Co Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Nissui Pharmaceutical Co Ltd
TSE:4550
Revenue
¥16.7B
CAGR 3-Years
10%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Hoya Corp
TSE:7741
Revenue
¥916.4B
CAGR 3-Years
9%
CAGR 5-Years
12%
CAGR 10-Years
6%
H
Hogy Medical Co Ltd
TSE:3593
Revenue
¥37.8B
CAGR 3-Years
-1%
CAGR 5-Years
1%
CAGR 10-Years
1%
A
Asahi Intecc Co Ltd
TSE:7747
Revenue
¥129.8B
CAGR 3-Years
15%
CAGR 5-Years
19%
CAGR 10-Years
13%
Mani Inc
TSE:7730
Revenue
¥39.1B
CAGR 3-Years
20%
CAGR 5-Years
21%
CAGR 10-Years
10%
Nipro Corp
TSE:8086
Revenue
¥652.6B
CAGR 3-Years
7%
CAGR 5-Years
8%
CAGR 10-Years
6%
No Stocks Found

Nissui Pharmaceutical Co Ltd
Glance View

Market Cap
38.3B JPY
Industry
Health Care

Nissui Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of culture media and diagnostic reagents for medical institutions, research organizations, and food industries. The company is headquartered in Taito-Ku, Tokyo-To and currently employs 250 full-time employees. is a Japan-based company mainly engaged in the manufacture, purchase and sale of clinical diagnostic drugs, industrial diagnostic drugs, pharmaceuticals, among others. The firm operates through two business segments. The Diagnostic Drug segment is involved in the manufacture, purchase and sale of culture media, clinical diagnostic drugs, industrial diagnostic drugs and raw materials for medical institutions, research institutions and industrial facilities, as well as the purchase and sale of testing equipment and other equipment. The Pharmaceutical segment is involved in the manufacture, purchase and sale of pharmaceuticals and health foods for pharmacies and drugstores. The Company’s main products include clinical diagnostic drugs, industrial diagnostic drugs such as compactdry, pharmaceuticals such as therapeutics, nourishing tonics and health foods.

Intrinsic Value
Not Available

See Also

What is Nissui Pharmaceutical Co Ltd's Revenue?
Revenue
16.7B JPY

Based on the financial report for Mar 31, 2022, Nissui Pharmaceutical Co Ltd's Revenue amounts to 16.7B JPY.

What is Nissui Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
5%

Over the last year, the Revenue growth was 39%. The average annual Revenue growth rates for Nissui Pharmaceutical Co Ltd have been 10% over the past three years , 5% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett